Breast cancer patient spared chemo through trial says it felt ‘like Christmas’
A major international clinical trial has found that many breast cancer patients can safely avoid chemotherapy by using a gene test called Prosigna to determine treatment necessity. Researchers estimate this could spare over 5,000 NHS patients annually from the physical and emotional burdens of unnecessary chemotherapy.
Why it matters
This discovery represents a significant advancement in personalized medicine, potentially improving the quality of life for thousands of cancer patients.
Breast cancer patient spared chemo through trial says it felt ‘like Christmas’ - Yahoo News Singapore
The article is a straightforward report on medical research findings and patient outcomes, maintaining a neutral and informative tone.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in